THC Pills Fail in Multiple Sclerosis Trial
In a rare setback involving the efficacy of medical marijuana, the preliminary results of a three-year clinical trial in the United Kingdom that administered THC pills to multiple sclerosis patients indicates cannabinoid consumption does not slow down the progression of the debilitating disease.
The study, involving 500 MS patients, costing a reported eight million pounds (almost 16.5 million U.S. dollars) and conducted by the Peninsula Medical School in Plymouth (a city in South …More
Leave a Reply
You must be logged in to post a comment.
